Cited by 107Computational Drug Discovery MethodsSARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design

Open access
Lv, Hao, Shi, Lei, Berkenpas, Joshua William, Dao, Fu-Ying, Zulfiqar, Hasan, Ding, Hui, Zhang, Yang, Yang, Liming +1 more·2021·Briefings in Bioinformatics

Abstract

The global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has led to a dramatic loss of human life worldwide. Despite many efforts, the development of effective drugs and vaccines for this novel virus will take considerable time. Artificial intelligence (AI) and machine learning (ML) offer promising solutions that could accelerate the discovery and optimization of new antivirals. Motivated by this, in this paper, we present an extensive survey on the application of AI and ML for combating COVID-19 based on the rapidly emerging literature. Particularly, we point out the challenges and future directions associated with state-of-the-art solutions to effectively control the COVID-19 pandemic. We hope that this review provides researchers with new insights into the ways AI and ML fight and have fought the COVID-19 outbreak.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bib/bbab320

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ML algorithms have been used to analyze large datasets of potential compounds and identify those with the most potential for treating COVID-19.

    “ML algorithms have been used to analyze large datasets of potential compounds and identify those with the most potential for treating the virus.”
  • In some cases, AI-powered approaches have identified promising drug candidates for COVID-19 in a fraction of the time that traditional methods would take.

    “In some cases, these AI-powered approaches have been able to identify promising drug candidates in a fraction of the time that it would take when using traditional methods [26,27,28,29,30,31].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Research works printed but not linked: 5

  1. Chenthamarakshan V, Das P, Padhi I, et al. Mojsilovic AJapa: target-specific and selective drug design for covid-19 using deep generative models. arXiv 2020. https://doi.org/2004.01215.
  2. Law JN, Akers K, Tasnina N, et al. Murali TJapa: identifying human interactors of SARS-CoV-2 proteins and drug targets for COVID-19 using network-based label propagation. arXiv 2020. https://doi.org/2006.01968.
  3. Unterthiner T, Mayr A, Klambauer G, Steijaert M, Wegner JK, Ceulemans H, Hochreiter S: Deep learning as an opportu- nity in virtual screening. In: Proceedings of the Deep Learning Workshop at NIPS: 2014; 2014: 1-9.
  4. Hsieh K, Wang Y, Chen L, et al. Drug repurposing for COVID- 19 using graph neural network with genetic, mechanistic, and epidemiological validation. arXiv 2020. https://doi.org/ 2009.10931.
  5. Zhavoronkov A, Aladinskiy V, Zhebrak A, et al. Orekhov PJIMHKLA: potential COVID-2019 3C-like protease inhibitors designed using generative deep learning approaches. Insilico Medicine Hong Kong Ltd A 2020;307:E1.

Cited by

Sorted by citations

Authors
Lv, H., Shi, L., Berkenpas, J. W., Dao, F.-Y., Zulfiqar, H., Ding, H., Zhang, Y., Yang, L., & Cao, R.
Affiliations
  • University of Electronic Science and Technology of China (CN)
  • Second Military Medical University (CN)
  • Pacific Lutheran University (US)
  • Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu 610054, China
  • Chengdu University of Traditional Chinese Medicine (CN)
  • Harbin Medical University (CN)
Corresponding author
  • Zhang, Yang
  • Yang, Liming
  • Cao, Renzhi
Venue
Briefings in Bioinformatics
Published
2021-08-18
Volume
22
Issue
6
ISSN
  • 1467-5463 (ISSN-L)
  • 1477-4054
OpenAlex
W3193314306
Cited by
107
References
71
Citations by year
2026: 12 · 2025: 15 · 2024: 28 · 2023: 22 · 2022: 29 · 2021: 1
FWCI
10.54
Type
journal article
Language
en
Open access
Locations
  • Briefings in Bioinformatics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Natural Sciences Undergraduate Research Program at Pacific Lutheran University
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
COVID-19 pandemic, SARS-CoV-2, drug discovery, vaccine design, artificial intelligence, machine learning, pandemic response
MeSH terms
Machine Learning, COVID-19, SARS-CoV-2, COVID-19 Vaccines, COVID-19 Drug Treatment, Artificial Intelligence, Humans, Drug Design, Drug Discovery, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review